BOARD of Directors
James (Jay) Galeota was the President and Chief Executive Officer of Inheris Biopharma, Inc., where he transformed the Nektar spinout, helping to build a new, independent pharmaceutical company in less than a year. Prior to Inheris, he was President of G&W Laboratories, Inc. where he oversaw business operations including research and development, commercial, manufacturing, business development, quality, supply chain, information technology, and corporate support functions. Mr. Galeota spent nearly 30 years with Merck & Co. where he held positions of increasing seniority and oversaw the global development and commercialization for multiple therapeutic areas, such as those in theDiabetes and Obesity Franchise. He was also the President of Merck’s Hospital and Specialty Care business line. He completed his career at Merck as Chief Strategy and Business Development officer and President of Emerging Business for the company. He received his B.S. in Biology from Villanova University, is a graduate of Harvard Business School’s Advanced Management Program, and completed Officer Field Training for the United States Air Force, Reserve Officer Training Corps. Mr. Galeota is also a member of Boards of Directors and Committees for multiple public and privately held companies.